Literature DB >> 28549121

Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities.

Lauren Brinkley-Rubinstein1,2, David L Rosen3, Paul Christopher4, Lauri Bazerman5, Curt G Beckwith5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28549121      PMCID： PMC5849091          DOI： 10.1093/cid/cix493

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  14 in total

1.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

Review 2.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

3.  Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention.

Authors:  Martin Markowitz; Kathrine Meyers
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

4.  Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.

Authors:  M J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Infect Dis       Date:  2011-05-01       Impact factor: 5.226

5.  Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.

Authors:  Ryan P Westergaard; Gregory D Kirk; Douglas R Richesson; Noya Galai; Shruti H Mehta
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

6.  Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.

Authors:  Evgeny Krupitsky; Edward V Nunes; Walter Ling; Ari Illeperuma; David R Gastfriend; Bernard L Silverman
Journal:  Lancet       Date:  2011-04-30       Impact factor: 79.321

Review 7.  Long-acting injectable contraception with depot medroxyprogesterone acetate.

Authors:  A M Kaunitz
Journal:  Am J Obstet Gynecol       Date:  1994-05       Impact factor: 8.661

8.  Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.

Authors:  Sandra A Springer; Edward Pesanti; John Hodges; Thomas Macura; Gheorghe Doros; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

9.  Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain.

Authors:  Deanna Kerrigan; Andrea Mantsios; Miguel Gorgolas; Maria-Luisa Montes; Federico Pulido; Cynthia Brinson; Jerome deVente; Gary J Richmond; Sarah W Beckham; Paige Hammond; David Margolis; Miranda Murray
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

10.  HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity.

Authors:  Anne C Spaulding; Ryan M Seals; Matthew J Page; Amanda K Brzozowski; William Rhodes; Theodore M Hammett
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240
View more
  4 in total

1.  Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.

Authors:  Amanda M Bunting; Carrie B Oser; Michele Staton; Katherine S Eddens; Hannah Knudsen
Journal:  Addict Sci Clin Pract       Date:  2018-12-03

2.  HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.

Authors:  Curt G Beckwith; Sugi Min; Akarsh Manne; Vladimir Novitsky; Mark Howison; Tao Liu; Irene Kuo; Ann Kurth; Lauri Bazerman; Anya Agopian; Rami Kantor
Journal:  AIDS Res Hum Retroviruses       Date:  2021-05-24       Impact factor: 1.723

3.  Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine.

Authors:  Gabriel G Edwards; Ayako Miyashita-Ochoa; Enrico G Castillo; David Goodman-Meza; Ippolytos Kalofonos; Raphael J Landovitz; Arleen A Leibowitz; Craig Pulsipher; Ed El Sayed; Steven Shoptaw; Chelsea L Shover; Michelle Tabajonda; Yvonne S Yang; Nina T Harawa
Journal:  AIDS Behav       Date:  2022-09-05

4.  Infectious disease surveillance in U.S. jails: Findings from a national survey.

Authors:  Morgan Maner; Marisa Omori; Lauren Brinkley-Rubinstein; Curt G Beckwith; Kathryn Nowotny
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.